Patterns of pharmacotherapy for bipolar disorder: A <scp>GBC</scp> survey
Balwinder Singh(Mayo Clinic), Melvin G. McInnis(University of Michigan), Kamyar Keramatian(University of British Columbia), Rebecca Strawbridge(King's College London), Katherine E. Burdick(Nathan Kline Institute for Psychiatric Research), Caitlin E. Millett(Brigham and Women's Hospital), Ole A. Andreassen(Oslo University Hospital), Ophélia Godin(Inserm), Mark A. Frye(Mayo Clinic), Lakshmi N. Yatham(University of British Columbia), Janice M. Fullerton(The University of Sydney), Anastasia K. Yocum(University of Michigan), Andrew A. Nierenberg(Andrews University), Sarah H. Sperry(University of Michigan), Marion Leboyer(Université Paris-Est Créteil), Brandon J. Coombes(Mayo Clinic in Florida), Norma Verdolini(University of Perugia), Giovanna Fico(Hospital Clínic de Barcelona), Joanna M. Biernacka, Gloria Roberts(South African Medical Research Council), Lana J. Williams(Barwon Health), Allan H. Young(King's College London), Eduard Vieta(Hospital Clínic de Barcelona), Peter P. Zandi(Johns Hopkins University), Bruno Étain(Inserm), Ivy F. Tso(The Ohio State University), Michael Berk(The Royal Melbourne Hospital), Amy T. Peters(Harvard University), Melanie M. Ashton(Barwon Health), Bronwyn J. Overs(Neuroscience Research Australia), Dániel Pham(Milken Institute), Ana C. Andreazza(University of Toronto), Philip B. Mitchell(UNSW Sydney)
Cited by 76
Related Papers
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k